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INTRODUCTION
Non-adherence to medication and treatment pro-
grammes by people with mental health problems is par-
ticularly common (Fenton et al., 1997; Lacro et al., 2002;
Nosé et al., 2003) and is associated with a range of neg-
ative outcomes. It may result in poorer outcomes for the
individual, for example, increased rates of relapse and re-
hospitalisation, as well as increasing the burden on health
services. The healthcare costs of patients with schizo-
phrenia who do not adhere to medication are reportedly
higher than the costs for those that do adhere (Gilmer et
al., 2004). It has been suggested that non-compliance
with treatment is a feature of at least a quarter of suicides
and homicides by people with mental health problems
(Appleby, 2000).
Several strategies such as compliance therapy, psy-
chotherapy, family education, telephone prompting and
psycho-education have been tested to improve adherence
to maintenance antipsychotic medication. Studies show
that they have at best, a limited effect (McDonald et al.,
2002; O’Donnell et al., 2003). Adherence therapy, which
aims to improve compliance with medication, is specifi-
cally not recommended for people with schizophrenia
(National Institute of Clinical Excellence, 2009). Against
this background, the question arises as to what initiatives
may be effective in improving adherence to treatment.
Research conducted in the United States has shown
that financial incentives can considerably improve adher-
ence to treatment in a range of conditions. A systematic
review found that 10 out of 11 randomised controlled
studies using financial incentives described positive
results for anti-tuberculosis drugs, dental care, weight
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reduction, cocaine dependence, and anti-hypertensive
treatment (Giuffrida & Togerson, 1997). None of these
studies were conducted with patients with psychiatric dis-
orders; however a clinical trial is currently underway in
the UK which seeks to examine the effectiveness of
financial incentives on adherence to anti-psychotic main-
tenance medication (Priebe et al., 2009).
Patient experiences of the use of leverage such as
money or housing to improve adherence to treatment in
psychiatric patients in the community have been explored
(Monahan et al., 2005). Half of the individuals reported
that a form of leverage had been used to encourage adher-
ence to treatment, with the provision of accommodation
being the most commonly used incentive.
There has been some ethical debate over the use of
financial incentives to achieve adherence in people with
mental health problems. While financial incentives could
be perceived as coercive (Shaw, 2007), others claim that
they should be interpreted as a reward and could be
viewed as less coercive than existing forms of leverage,
such as enforced hospital admission (Burns, 2007). While
this controversial debate is likely to continue for concep-
tual, ethical and practical reasons, the debate should be
informed by evidence on the use of financial incentives for
treatment adherence in severely mentally ill populations.
Aims of the study
To systematically review the existing published litera-
ture on whether financial or material incentives improve
adherence to treatment in people with severe mental illness.
MATERIAL AND METHODS
An initial broad search for articles was undertaken to
identify all studies where financial and material incen-
tives have been used to achieve adherence to treatment in
people with severe mental illness. Articles where finan-
cial or material incentives were offered to severely men-
tally ill patients to improve adherence to substance mis-
use treatment programmes were included in the review.
Relevant studies were located through a search of the
following databases up to October 2008: EBM (1991+),
PsychINFO (1950+), EMBASE (1980+), Medline
(1950+) and AMED (1985+). The following search
terms were combined simultaneously to identify relevant
studies: ‘incentive’, ‘money’, ‘payment’ ‘contingency
management’, ‘voucher’, ‘financial’ with the terms
‘medication’, ‘therapy’, ‘appointment’ ‘compliance’
‘adherence’ and ‘mental health’, ‘mental illness’, or
‘psychiatr’ to identify studies specific to severely men-
tally ill populations.
The reference lists of relevant articles identified
through this process were hand searched to identify any
further research articles. All four authors of the mental
health treatment specific articles were contacted to iden-
tify whether any other relevant studies existed. Three
responded and identified no further studies beyond those
included in this review. Ten key psychiatry journals
including Acta Psychiatrica Scandinavica, American
Journal of Psychiatry, Archives of General Psychiatry,
British Journal of Psychiatry, Journal of Clinical
Psychiatry, Epidemiologia E Psichiatria Sociale,
Psychopharmacology, Journal of Social Psychiatry and
Psychiatric Epidemiology, Schizophrenia Bulletin and
Psychiatric Services were manually searched for relevant
articles from the previous five years (January 2004-
January 2009), but yielded no further results.
Papers were selected for inclusion in the review using
the following criteria: the incentive had to be a direct
offer of payment to an individual in the form of a mone-
tary, voucher based or material goods value before they
received treatment. The impact the incentive had on
adherence had to be reported and participants had to be
diagnosed with a severe mental illness. Data were
extracted from each study by two research workers and
compared to ensure reliability of the extraction tool.
Where discrepancies appeared, these were discussed until
a consensus was reached.
Due to the expectation that limited research would be
found in this area, the inclusion criteria for study method-
ologies was not restricted to randomised controlled trials.
A Meta Analysis was not conducted on the data, as it was
anticipated that studies would be too heterogeneous with
regards to the interventions, treatment settings, partici-
pant diagnoses, and outcomes measured. A descriptive
synthesis of the results is therefore presented.
RESULTS
From the databases searched, 90 articles were retrieved
for further screening (See Figure 1). Fifty-four articles
were excluded as they referred specifically to people with
substance misuse disorders with no other diagnosed men-
tal health problem. A further 28 articles were excluded as
the incentive was not of a financial or material value.
Eight studies selected for inclusion were identified direct-
ly from the database search. In one of these studies
(Messina et al., 2003), participants either had a substance
A. Burton, S. Marougka, S. Priebe
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misuse problem or a diagnosis of antisocial personality
disorder (ASPD) and substance misuse problem. Only the
outcomes from the ASPD group are taken into account for
the purposes of this review. The remaining six articles
were identified through a manual search of the bibliogra-
phies from articles with a related title.
From the 14 articles that met the inclusion criteria,
three sought to encourage adherence to mental health
specific treatments (Claassen et al., 2007; Post et al.,
2006; Olson & Greenberg, 1979). This included adher-
ence to depot medication for people with schizophrenia
(Claassen et al., 2007), attendance at therapy sessions
for people with depression (Post et al., 2006), and atten-
dance and active participation in group meetings for
people with schizophrenia and other disorders (Olson &
Greenberg, 1979). One study aimed to encourage the
uptake of physical exercise in people with schizophre-
nia (Thyer et al., 1984). The remaining ten studies
offered financial or material incentives to people with
severe mental illness to encourage abstinence from sub-
stances and/or adherence to substance misuse treatment
programmes. This included two studies on abstinence
from smoking in people with schizophrenia (Carey &
Carey, 1990; Tidey et al., 2002). See Tables I and II for
study details.
Study Participants
Study participants were either outpatients, living in
independent accommodation or hostels in the community,
living in the community and accessing assertive outreach
services, or psychiatric inpatients. In seven of the studies,
participants were diagnosed with schizophrenia or other
psychotic disorders. One study included people with
depression (Post et al., 2006) while another included peo-
ple with ASPD (Messina et al., 2003). In the remaining
five studies, participants had a range of mental disorders.
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Studies retrieved for more detailed
evaluation and check of references
Potentially appropriate studies to be
included in the systematic review
Studies included from database
search n = 8
Total number of studies included
n = 14
Studies excluded n = 54
Studies excluded from
systematic review n = 28
Studies found in reference lists
of relevant articles n = 6
Figure 1 - QUOROM diagram.
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Study Design
Nine studies utilised a time series study
design with no control group. There was one case
observation study (Claassen et al., 2007) one
controlled trial for active involvement in inpa-
tient group meetings (Olson & Greenberg 1979)
and three randomised controlled trials; two
examining the effect of offering incentives to
promote abstinence from substances (Messina et
al., 2003, Tracy et al., 2007), and one for a com-
bination of attendance at compensated work ther-
apy and abstinence from substances (Drebbing et
al., 2005).
In three out of the ten studies aiming to reduce
substance and alcohol misuse, the incentive was
given for participation in therapy as well as for the
provision of a drug negative sample. All studies
were conducted in the United States with the
exception of one UK based study (Claassen et al.,
2007), and were undertaken between 1972 and
2007. The intervention periods lasted between one
week and 40 weeks with one study not specifying
an end point (Claassen et al., 2007), The sample
sizes varied from between two and 120 patients,
with nine of the studies containing a sample size
of less than 30 participants.
Incentives used
The type of incentive used was either in the
form of a direct payment of money or vouchers
and in one study, money or vouchers alongside
three bus passes a week (Olson & Greenberg,
1979). The maximum possible incentive that
could be earned in each study ranged from $12
to $1,277.50. Where vouchers were offered,
these could be exchanged for goods either in the
shops of each centre, or on activities that were
estimated to be valued by the participants, such
as fast food, bowling and days out. Two studies
used material goods as the incentive.
Participants were given an extra allowance of
tea, coffee or cigarettes or could win prizes from
a lucky dip. An extra payment was given inde-
pendent of the intervention in seven of the stud-
ies, usually after participants completed baseline
assessments.
In the three studies focusing on psychiatric
treatment, patients were offered £5-£15 per depot
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injection received (Claassen et al., 2007), $10 per thera-
py appointment attended, usually one a week for a 12-
week period (Post et al., 2006), and a maximum of $15
dollars a week for a 16 week period (Olson & Greenberg,
1979) dependent on attendance and participation in
patient group meetings.
Outcomes
All of the studies found that the use of financial incen-
tives can improve adherence to mental health treatment
or abstinence from substances. The results show that dur-
ing the intervention phase, when the incentive was
offered, adherence to treatment and abstinence from sub-
stances improved when compared with baseline assess-
ments, with eleven of the fourteen studies reporting this
improvement as significant. Six out of the eleven studies
that included a post intervention assessment demonstrat-
ed an improvement in adherence from the first baseline
assessment; where measurements were recorded before
the incentive was introduced, and the post intervention
phase; where the incentive had been taken away and
adherence was measured again. This improvement was
only reported as significant in one of the studies. Messina
et al., 2003 demonstrated that abstinence from cocaine
remained significantly higher at 52 week follow up
(between 71% and 80% of cocaine samples provided
were negative in the incentive conditions compared with
20% in the control group).
Claassen et al. (2007) reported that four out of five
patients who were offered a financial incentive to
adhere to depot medication accepted; three had
improved adherence to medication after money was
offered and were not re-hospitalised during the incen-
tive phase. The forth participant had improved adher-
ence, however was re-hospitalised. Post et al. (2006)
found that attendance at therapy sessions significantly
increased from 79% in the pre incentive period, to 86%
during the intervention phase, however this significant-
ly decreased to 69% once the incentive payments were
discontinued. Thyer et al. (1984) found that participants
increased the amount of physical exercise they did dur-
ing the intervention phase and that this was maintained
50 days after the incentive was withdrawn (no statistical
analyses reported) while Olsen & Greenburg (1972)
reported that the incentive group spent more days on
leave from hospital than the control groups at 16 week
follow up and had a significantly increased level of
attendance at scheduled groups during the incentive
period (no follow up).
DISCUSSION
The literature in this review suggests that offering
financial or material incentives to people with a severe
mental illness can improve adherence to treatment during
the period of time in which the incentive is offered.
Where follow up is documented however, five out of the
eleven studies that carried out a post intervention assess-
ment suggest that adherence deteriorates back to baseline
levels or worse once the incentive is taken away. The
remaining six studies maintained improved adherence,
however only one study demonstrated significantly
improved adherence levels when compared o baseline
assessments (Messina et al., 2003).
The strengths of this review are the systematic nature
in which articles were extracted. We utilised a range of
search methods and search terms including database and
manual journal searches, as well as contacting experts to
verify that no other published research on this topic
existed.
The weaknesses of this review are the lack of homo-
geneity between studies, making it difficult to combine
outcome measures and thus form a coherent conclu-
sion applicable to a clearly defined population.
Nevertheless we wanted to be as broad as possible in
our search for articles specific to the severely mental-
ly ill population due to a presumed lack of research in
the field.
Financial incentives have been found to be success-
ful in modifying a range of health behaviours
(Jochelson, 2007), therefore the potential they may have
in influencing adherence to treatment among people
with mental health problems should not be underesti-
mated. Research specific to mental health settings is
however limited to a small number of studies, with most
of the research aimed at improving adherence to sub-
stance misuse treatment programmes and the provision
of drug negative samples.
There are also methodological problems with the
majority of studies included in this review. There are very
few randomised controlled trials on financial incentives
in this population, and 10 of the studies included in this
review lacked a control group. Small sample sizes may
impact on the generalisabilty of results to a wider popu-
lation. Many studies do not include a follow up period
beyond a post intervention assessment immediately after
the incentive has been withdrawn, meaning that only
short term conclusions regarding effectiveness can be
reached. Three of the studies do not report statistical
analyses on the data; therefore the significance of these
results cannot be reported.
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The finding in five of the studies, that adherence lev-
els decline once the incentive is taken away, raises a prac-
tical issue as to the length of time incentive schemes
should be implemented in order to achieve long-term
treatment compliance. This is not addressed by the exist-
ing research. A consideration of why patients may dis-
continue treatment once incentives are withdrawn is also
absent from the research. Nose 2008 suggests that future
research on medication adherence should take in to con-
sideration the impact of side effects from both the patient
and clinician perspective. What the existing research
does suggest however is that even an offer of a small
financial incentive has the potential to increase adherence
to treatment during that time. 
All but one of the studies were conducted in United
States healthcare settings. The transferability of results
to European models of healthcare needs to be treated
with caution. For example, although the assertive out-
reach model appears to be effective in the United States,
it was found to be no more effective than the care pro-
vided by community mental health teams in the UK
(Burns et al., 2007; Killaspy et al., 2006). In the same
way, financial incentives may not have the same impact
when utilised outside of the United States insurance-
based healthcare system.
Concerns have been raised around the acceptability
of offering financial incentives to achieve mental health
treatment adherence. Post et al. (2006) claim that it may
be difficult to implement an incentive scheme at policy
level because of differing opinions on whether patient
payments are acceptable. The authors also reported that
52% of participants would attend therapy sessions for
money even if they found the session unhelpful, which
brings into question the impact that incentives may have
on patient outcomes beyond simply turning up to treat-
ment sessions. Olsen & Greenberg (1972) found that
although attendance at group sessions increased with
the introduction of incentives, patients in the incentive
group demanded that the incentive program stop
because they felt that their human rights were being
deprived.
The results from this review suggest that financial
incentives could be used as an effective tool for initiating
engagement in mental health treatment and abstinence
from substances. Further robust research is required to
determine the long term effectiveness of financial incen-
tives on improving adherence to treatment, as well as the
impact incentives may have on patient outcomes, patient
attitudes to treatment and the potential effect incentives
may have on the therapeutic relationship between patient
and clinician.
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